Table 2.
IC | PFS | OS | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | Univariate | Multivariate | ||||||||||||||
Factors | Level | P | HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI |
Gender | Male | ||||||||||||||||||
Female | 0.035 | 0.435 | 0.2–0.944 | 0.04 | 0.443 | 0.204–0.962 | 0.084 | 0.612 | 0.35–1.068 | 0.005 | 0.421 | 0.232–0.767 | 0.005 | 0.381 | 0.193–0.75 | ||||
Age, median (IQR) | 0.192 | 0.987 | 0.969–1.006 | 0.297 | 0.992 | 0.976–1.007 | 0.579 | 0.995 | 0.98–1.012 | ||||||||||
ECOG | 0 | ||||||||||||||||||
1 | 0.463 | 1.257 | 0.682–2.316 | 0.381 | 1.25 | 0.758–2.062 | 0.475 | 1.206 | 0.722–2.015 | ||||||||||
Hepatitis B virus | Negative | ||||||||||||||||||
Positive | 0.503 | 1.224 | 0.678–2.21 | 0.357 | 1.253 | 0.775–2.025 | 0.29 | 1.303 | 0.798–2.128 | ||||||||||
KPS, median (IQR) | 0.222 | 0.98 | 0.948–1.013 | 0.058 | 0.973 | 0.946–1.001 | 0.028 | 0.968 | 0.941–0.996 | 0.019 | 0.965 | 0.937–0.994 | |||||||
Tbil, median (IQR) | 0.669 | 1.001 | 0.995–1.007 | 0.53 | 1.002 | 0.997–1.007 | 0.014 | 1.006 | 1.001–1.01 | 0.418 | 1.004 | 0.995–1.013 | |||||||
Albumin, median (IQR) | 0.054 | 0.949 | 0.899–1.001 | 0.037 | 0.954 | 0.913–0.997 | 0.464 | 0.966 | 0.882–1.059 | 0.006 | 0.939 | 0.898–0.982 | 0.501 | 0.948 | 0.811–1.108 | ||||
Tumor size, median (IQR) | 0.705 | 1.013 | 0.948–1.082 | 0.886 | 1.004 | 0.95–1.061 | 0.516 | 1.018 | 0.964–1.076 | ||||||||||
Urea, median (IQR) | 0.913 | 0.992 | 0.862–1.142 | 0.729 | 0.979 | 0.87–1.102 | 0.708 | 0.978 | 0.868–1.101 | ||||||||||
ALP median (IQR) | 0.878 | 1 | 0.998–1.002 | 0.191 | 1.001 | 1–1.002 | 0.034 | 1.001 | 1–1.002 | 0.218 | 1.001 | 0.999–1.002 | |||||||
PT, median (IQR) | 0.651 | 1.03 | 0.907–1.169 | 0.969 | 1.002 | 0.899–1.117 | 0.63 | 1.028 | 0.919–1.149 | ||||||||||
ALBI score, median (IQR) | 0.068 | 1.641 | 0.964–2.795 | 0.045 | 1.574 | 1.011–2.452 | 0.931 | 1.043 | 0.402–2.705 | 0.001 | 2.087 | 1.347–3.236 | 0.731 | 0.735 | 0.128–4.235 | ||||
AFP, median (IQR) | 0.16 | 1 | 43831 | 0.099 | 1 | 43831 | 0.015 | 1 | 1.0–1.0 | 0.087 | 1 | 1.0–1.0 | |||||||
RT dose, median (IQR) | 0.094 | 0.975 | 0.947–1.004 | 0.133 | 0.981 | 0.957–1.006 | 0.09 | 0.978 | 0.953–1.003 | 0.073 | 0.977 | 0.953–1.002 | |||||||
Tumor number | 1 | 0.93 | 0.931 | 0.865 | |||||||||||||||
2 | 0.749 | 0.862 | 0.348–2.136 | 0.747 | 0.881 | 0.409–1.898 | 0.653 | 0.828 | 0.363–1.887 | ||||||||||
≥3 | 0.815 | 0.92 | 0.459–1.844 | 0.823 | 0.936 | 0.525–1.67 | 0.794 | 1.081 | 0.604–1.934 | ||||||||||
Cheng's type of PVTT | I | 0.749 | 0.595 | 0.308 | |||||||||||||||
IIa | 0.921 | 1.061 | 0.329–3.419 | 0.821 | 0.9 | 0.362–2.24 | 0.653 | 0.811 | 0.325–2.023 | ||||||||||
IIb | 0.915 | 0.906 | 0.151–5.448 | 0.373 | 1.719 | 0.522–5.665 | 0.382 | 1.699 | 0.517–5.58 | ||||||||||
III | 0.557 | 1.431 | 0.433–4.731 | 0.938 | 1.038 | 0.405–2.662 | 0.717 | 0.839 | 0.325–2.168 | ||||||||||
IV | 0.472 | 1.932 | 0.322–11.609 | 0.428 | 1.786 | 0.425–7.504 | 0.305 | 2.125 | 0.503–8.971 | ||||||||||
IVCTT | 0.846 | 0.872 | 0.218–3.492 | 0.744 | 0.836 | 0.285–2.452 | 0.452 | 0.656 | 0.218–1.97 | ||||||||||
Child–Pugh | A | ||||||||||||||||||
B | 0.882 | 1.061 | 0.489–2.302 | 0.472 | 1.244 | 0.686–2.258 | 0.005 | 2.23 | 1.269–3.921 | 0.594 | 1.259 | 0.541–2.928 | |||||||
TACE | No | ||||||||||||||||||
Yes | 0.137 | 0.709 | 0.451–1.115 | 0.164 | 0.725 | 0.46–1.14 | 0.044 | 0.679 | 0.466–0.989 | 0.123 | 0.735 | 0.497–1.087 | 0.003 | 0.56 | 0.382–0.821 | 0.037 | 0.648 | 0.43–0.975 |